Cargando…
The anticoagulation length of therapy and risk of new adverse events in venous thromboembolism (ALTERNATIVE) study: Design and survey results
The Anticoagulation Length of Therapy and Risk of New Adverse Events In Venous Thromboembolism (ALTERNATIVE) study was designed to compare the benefits and harms of different treatment options for extended treatment of venous thromboembolism (VTE). In this paper, we describe the study cohort, survey...
Autores principales: | Portugal, Cecilia, Fang, Margaret C., Go, Alan S., Zhou, Hui, Chang, John, Prasad, Priya, Fan, Dongjie, Garcia, Elisha A., Sung, Sue Hee, Reynolds, Kristi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731472/ https://www.ncbi.nlm.nih.gov/pubmed/36480548 http://dx.doi.org/10.1371/journal.pone.0277961 |
Ejemplares similares
-
Clinical Outcomes of Direct Oral Anticoagulants vs Warfarin for Extended Treatment of Venous Thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2023) -
Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021) -
Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19
por: Fang, Margaret C., et al.
Publicado: (2023) -
COVID-19 and Risk of VTE in Ethnically Diverse Populations
por: Go, Alan S., et al.
Publicado: (2021) -
New anticoagulants for the prevention of venous thromboembolism
por: Becattini, Cecilia, et al.
Publicado: (2010)